477 filings
8-K
MSLPQ
MusclePharm Corp
31 Aug 23
Departure of Directors or Certain Officers
5:23pm
8-K
MSLPQ
MusclePharm Corp
19 Jul 23
Departure of Directors or Certain Officers
3:06pm
8-K
MSLPQ
MusclePharm Corp
10 Mar 23
Departure of Directors or Certain Officers
4:16pm
8-K
MSLPQ
MusclePharm Corp
11 Jan 23
Bankruptcy or Receivership
5:02pm
8-K
MSLPQ
MusclePharm Corp
10 Jan 23
Changes in Registrant's Certifying Accountant
7:37pm
8-K
jpksx 0qpfsjvvl
9 Jan 23
Bankruptcy or Receivership
2:41pm
8-K
qpmbs0klbg3o
29 Sep 22
Departure of Directors or Certain Officers
4:33pm
8-K
hca3qz3q4m2i8z
16 Sep 22
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:43pm
8-K
5jt6z zhgja06d8f6sxh
23 Aug 22
Departure of Directors or Certain Officers
4:53pm
8-K
kim3aui
22 Aug 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:09pm
NT 10-Q
1iaaedyifytf8
16 Aug 22
Notice of late quarterly filing
5:54pm
8-K
ac7blnrrvn5ebq67
28 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
ufe6e3d
12 Jul 22
Departure of Directors or Certain Officers
5:00pm
8-K
r45sgm56bfy
22 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
fs8vtn5x0u334u0
14 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
v44muxtaemo
9 Jun 22
Entry into a Material Definitive Agreement
4:27pm
8-K
madhk qq1hhp3ehm64
17 May 22
MusclePharm Announces First Quarter 2022 Financial Results
4:15pm
8-K
kg30v 6skuj
5 May 22
Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021
4:55pm